Results 71 to 80 of about 10,346 (205)

Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan [PDF]

, 2012
This study aimed to describe the epidemiologic characteristics of microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) in Japan.
Kurosawa, Michiko, Makino, Hirofumi, Sada, Ken-ei, Sugiyama, Koichi, Wada, Jun   +4 more
core   +1 more source

Detection of Diagnostic Antibodies in Immune‐Mediated Diseases: A Focus on Antigens and Technologies

ChemBioChem, Volume 27, Issue 9, 14 May 2026.
This review explores autoantibody detection in immune‐mediated diseases, highlighting autoantigens including post‐translational modifications. We compared enzyme‐linked immunosorbent assay and indirect immunofluorescence with automated chemiluminescence platforms.
Silvia Bracci, Feliciana Real‐Fernandez, Federico Pratesi, Francesca Nuti, Paolo Rovero, Anna Maria Papini   +5 more
wiley   +1 more source

The role of pain, perseverative cognition and goal adjustment in vasculitis associated fatigue. [PDF]

, 2016
Fatigue is a common symptom associated with Vasculitis and contributes significantly to impaired quality of life. Motivational Control Theory (Hockey, 2013) suggests a role for perseverative cognition and goal adjustment in fatigue. Therefore, this study
Helen Mayor, John Reidy, Lin JM, Williams ACDC   +3 more
core   +1 more source

Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab

Arthritis &Rheumatology, Volume 78, Issue 5, Page 1134-1144, May 2026.
Objective The objective of the study was to determine risk factors for relapse of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) after reinduction of remission with rituximab and discontinuation of maintenance therapy. Methods This is a post hoc analysis of the RITAZAREM clinical trial.
Ellen Romich, Joshua F. Baker, Thomas R. Riley IV, Ian Green, Rennie L. Rhee, Carol A. McAlear, Ulrich Specks, Rona M. Smith, David R. Jayne, Peter A. Merkel, for the RITAZAREM Investigators, Reem Al‐jayyousi, Yoshihiro Arimura, Jacqueline Andrews, Simon Bond, Marianna Nodale, Annette Bruchfeld, Brian Camilleri, Simon Carette, Chee Kay Cheung, Michael Clarkson, Janak de Zoysa, Vimal Derebail, Tim Doulton, Tomomi Endo, Eri Muso, Tatsuo Tsukamoto, Alastair Ferraro, Lindsy Forbess, Shouichi Fujimoto, Shunsuke Furuta, Ora Gewurz‐Singer, Yoshitomo Hamano, Lorraine Harper, Toshiko Ito‐Ihara, Rachel B. Jones, Nader Khalidi, Rainer Klocke, Curry L. Koening, Yoshinori Komagata, Hajime Kono, Shunya Uchida, Carol A. Langford, Peter Lanyon, Sarah Lawman, Raashid Luqmani, Larry W. Moreland, Kim Mynard, Patrick Nachman, Christian Pagnoux, Chen Au Peh, Charles Pusey, Dwarakanathan Ranganathan, Ken‐ei Sada, Richard Smith, Richard Watts, Robert Spiera, Antoine G. Sreih, Kazuo Suzuki, Vladamir Tesar, Augusto Vaglio, Giles Walters, Caroline Wroe   +62 more
wiley   +1 more source

Ultra-Wide-Field Fluorescein Angiography in Microscopic Polyangiitis

Case Reports in Ophthalmological Medicine, 2016
A 25-year-old Hispanic female presented with 5 months of dry eyes and 2 months of bilateral photophobia and decreased vision. On examination, she had bilateral anterior uveitis and mild disc edema of the left eye.
Philip P. Storey, Shannon A. Philander, Anna Ter-Zakarian, Narsing A. Rao, Damien C. Rodger   +4 more
doaj   +1 more source

The Current Use and Future Perspectives of Biosimilars in Pediatric Healthcare: A Narrative Review

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims The integration of biosimilars into pediatric healthcare represents a significant evolution in treatment accessibility and cost‐effectiveness. Biosimilars—biological products highly similar to already approved biologics, have emerged as promising alternatives for managing chronic and rare pediatric conditions, including ...
Zubaier Ahmed, Tasfiah Tasnim Maha, Sanjana Nowsher, Wasima Taslim, Fatema‐Tuz‐Zohora, Sabrina Sharmin, Hasina Yasmin   +6 more
wiley   +1 more source

Lung involvement at presentation predicts disease activity and permanent organ damage at 6, 12 and 24 months follow - up in ANCA - associated vasculitis. [PDF]

, 2014
BACKGROUND: Antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis (AAV) may present with pulmonary involvement ranging from mild to life-threatening disease such as diffuse alveolar hemorrhage.
Gunaratnam, Cedric, Hassan, Astrid S, Hassan, Tidi M, Igoe, Ann, Logan, Mark, McElvaney, Noel G, O\u27Neill, Shane J   +6 more
core   +1 more source

The Role of Extracorporeal Membrane Oxygenation in Cardiopulmonary Dysfunction Due to Rheumatologic Diseases: A Systematic Review

ACR Open Rheumatology, Volume 8, Issue 4, April 2026.
Objective This systematic review documents the current status of extracorporeal membrane oxygenation (ECMO) use in patients with complications of rheumatologic diseases. Methods Following Preferred Reporting Items for Systematic Reviews and Meta Analyses 2020 guidelines, we conducted a systematic review of studies published from January 2019 to ...
Kari L. Falaas, Lyubov Y. Tiegs, Nicole Theis‐Mahon, Elie Gertner   +3 more
wiley   +1 more source

Characteristics of articular syndrome in systemic vasculitis [PDF]

, 2017
The purpose of the study – investigation the separate joint lesion in systemic vasculitis, their X-ray sonographic characteristics, the correlation of the articular syndrome severity with extra-articular manifestations of the diseases, as well as ...
Gashynova, K., Khaniukov, O., Syniachenko, O., Taktashov, H., Yehudina, Ye.   +4 more
core  

Wegener-granulomatosis [PDF]

, 2015
A Wegener-granulomatosis a kis és közepes átmérőjű erek granulomaképződéssel járó nekrotizáló gyulladása. Súlyosság és klinikai megjelenés szempontjából a betegség igen széles skálát mutat.
Csákó László,, Domján, Gyula, Gadó, Klára, Z Szabó László,   +3 more
core   +1 more source